Search by Drug Name or NDC
NDC 00409-3382-21 Sufentanil Citrate 50 ug/mL Details
Sufentanil Citrate 50 ug/mL
Sufentanil Citrate is a EPIDURAL; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is SUFENTANIL CITRATE.
Product Information
| NDC | 00409-3382 |
|---|---|
| Product ID | 0409-3382_4f948c10-c423-451b-af5c-29fafa52c987 |
| Associated GPIs | 65100090102010 65100090102015 65100090102030 |
| GCN Sequence Number | 030724 |
| GCN Sequence Number Description | sufentanil citrate VIAL 50 MCG/ML INTRAVEN |
| HIC3 | H3H |
| HIC3 Description | OPIOID ANALGESIC, ANESTHETIC ADJUNCT AGENTS |
| GCN | 28882 |
| HICL Sequence Number | 001749 |
| HICL Sequence Number Description | SUFENTANIL CITRATE |
| Brand/Generic | Generic |
| Proprietary Name | Sufentanil Citrate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | SUFENTANIL CITRATE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | EPIDURAL; INTRAVENOUS |
| Active Ingredient Strength | 50 |
| Active Ingredient Units | ug/mL |
| Substance Name | SUFENTANIL CITRATE |
| Labeler Name | Hospira, Inc. |
| Pharmaceutical Class | Full Opioid Agonists [MoA], Opioid Agonist [EPC] |
| DEA Schedule | CII |
| Marketing Category | ANDA |
| Application Number | ANDA074534 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00409-3382-21 (00409338221)
| NDC Package Code | 0409-3382-21 |
|---|---|
| Billing NDC | 00409338221 |
| Package | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-3382-21) / 1 mL in 1 VIAL, SINGLE-DOSE (0409-3382-11) |
| Marketing Start Date | 2005-07-26 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |